For example, ADAM9 promotes the invasion and metastasis of cancer cells in melanoma by activating MMP1 and MMP2, while ADAM17 can activate MMP2 to treat the disease (prostate cancer and lung injury) by promoting angiogenesis (35, 36). Here, ADAM9 is linked to prostate carcinoma.